Specific small nucleolar RNA expression profiles in acute leukemia

Leukemia

Volumn 26, Issue 9, 2012, Pages 2052-2060

  Valleron, W ^a   Laprevotte, E ^a   Gautier, E F ^a   Quelen, C ^a   Demur, C ^a,b   Delabesse, E ^a,b   Agirre, X ^c   Prosper F ^c   Kiss, T ^d   Brousset, P ^a,b  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b CHU PURPAN   (France)

^c UNIVERSITY OF NAVARRA   (Spain)

^d Université Paul Sabatier   (France)

Author keywords

acute leukemia; DLK1 DIO3; PML RARalpha; SnoRNA

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P16; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SMALL NUCLEOLAR RNA; SMALL NUCLEOLAR RNA D112; SMALL NUCLEOLAR RNA D113; SMALL NUCLEOLAR RNA D114; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; QUANTITATIVE ASSAY; RNA TRANSCRIPTION; S PHASE CELL CYCLE CHECKPOINT;

BLAST CRISIS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL NUCLEOLAR; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84865862599     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.111     Document Type: Article

References (43)

1. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838. (Pubitemid 40839735)
2. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866. (Pubitemid 44629897)
3. Kiss T. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell 2002; 109: 145-148. (Pubitemid 34518252)
4. Kiss T, Filipowicz W. Exonucleolytic processing of small nucleolar RNAs from premRNA introns. Genes Dev 1995; 9: 1411-1424.
5. Dieci G, Preti M, Montanini B. Eukaryotic snoRNAs: a paradigm for gene expression flexibility. Genomics 2009; 94: 83-88.
6. Decatur WA, Fournier MJ. rRNA modifications and ribosome function. Trends Biochem Sci 2002; 27: 344-351. (Pubitemid 34756517)
7. Decatur WA, Fournier MJ. RNA-guided nucleotide modification of ribosomal and other RNAs. J Biol Chem 2003; 278: 695-698. (Pubitemid 36790737)
8. Cavaille J, Buiting K, Kiefmann M, Lalande M, Brannan CI, Horsthemke B et al. Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc Natl Acad Sci USA 2000; 97: 14311-14316. (Pubitemid 32016572)
9. Runte M, Huttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K. The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum Mol Genet 2001; 10: 2687-2700. (Pubitemid 33133410)
10. Gallagher RC, Pils B, Albalwi M, Francke U. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet 2002; 71: 669-678. (Pubitemid 34970140)
11. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, Taylor M et al. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer 2011; 104: 1168-1177.
12. Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W et al. Implication of snoRNA U50 in human breast cancer. J Genet Genomics 2009; 36: 447-454.
13. Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet 2008; 17: 1031-1042. (Pubitemid 351426037)
14. Mei YP, Liao JP, Shen JP, Yu L, Liu BL, Liu L et al. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 2011; e-pub ahead of print 10 October 2011.
15. Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 2008; 3: e2141.
16. Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, Hu S et al. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 2011; 121: 1217-1221.
17. Marcucci G, Radmacher MD, Maharry K, Mrozek K, Ruppert AS, Paschka P et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1919-1928. (Pubitemid 351620112)
18. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008; 111: 3183-3189.
19. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007; 67: 2456-2468. (Pubitemid 46548930)
20. Cavaille J, Seitz H, Paulsen M, Ferguson-Smith AC, Bachellerie JP. Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region. Hum Mol Genet 2002; 11: 1527-1538. (Pubitemid 34679253)
21. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaille J. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 2004; 14: 1741-1748. (Pubitemid 39276432)
22. Tierling S, Dalbert S, Schoppenhorst S, Tsai CE, Oliger S, Ferguson-Smith AC et al. High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12. Genomics 2006; 87: 225-235. (Pubitemid 43117443)
23. Dulaney AM, Murgatroyd RJ. Use of trans-retinoic acid in the treatment of acute promyelocytic leukemia. Ann Pharmacother 1993; 27: 211-214. (Pubitemid 23062143)
24. Sakajiri S, O'Kelly J, Yin D, Miller CW, Hofmann WK, Oshimi K et al. Dlk1 in normal and abnormal hematopoiesis. Leukemia 2005; 19: 1404-1410. (Pubitemid 41136335)
25. Lubbert M, Miller CW, Crawford L, Koeffler HP. p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression. J Exp Med 1988; 167: 873-886.
26. Rui HB, Su JZ. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation. Haematologica 2002; 7: 136-142.
27. Butler AP, Trono D, Coletta LD, Beard R, Fraijo R, Kazianis S et al. Regulation of CDKN2A/B and retinoblastoma genes in xiphophorus melanoma. Comp Biochem Physiol C Toxicol Pharmacol 2007; 145: 145-155. (Pubitemid 46205464)
28. Mizuarai S, Machida T, Kobayashi T, Komatani H, Itadani H, Kotani H. Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples. Mol Cancer 2011; 10: 31.
29. Guo SX, Taki T, Ohnishi H, Piao HY, Tabuchi K, Bessho F et al. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leuk Res 2000; 24: 39-46.
30. Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J. Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res 2010; 39: 675-686.
31. Ender C, Krek A, Friedlander MR, Beitzinger M, Weinmann L, Chen W et al. A human snoRNA with microRNA-like functions. Mol Cell 2008; 32: 519-528.
32. Kishore S, Khanna A, Zhang ZY, Hui JY, Balwierz PJ, Stefan M et al. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Human Molecular Genetics 2010; 19: 1153-1164.
33. Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006; 311: 230-232. (Pubitemid 43108188)
34. Mitchell JR, Cheng J, Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 30 end. Mol Cell Biol 1999; 19: 567-576. (Pubitemid 29018458)
35. Ono M, Scott MS, Yamada K, Avolio F, Barton GJ, Lamond AI. Identification of human miRNA precursors that resemble box C/D snoRNAs. Nucleic Acids Res 2011; 39: 3879-3891.
36. Martens JH, Brinkman AB, Simmer F, Francoijs KJ, Nebbioso A, Ferrara F et al. PML-RARalpha/RXR alters the epigenetic landscape in acute promyelocytic leukemia. Cancer Cell 2010; 17: 173-185.
37. Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010; 17: 13-27.
38. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9: 435-443. (Pubitemid 43832188)
39. Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008; 27: 378-386.
40. Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 2011; 129: 773-779.
41. Kornblau SM, Xu HJ, Zhang W, Hu SX, Beran M, Smith TL et al. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 1994; 84: 256-261. (Pubitemid 24193828)
42. Paggi MG, de Fabritiis P, Bonetto F, Amadio L, Santarelli G, Spadea A et al. The retinoblastoma gene product in acute myeloid leukemia: a possible involvement in promyelocytic leukemia. Cancer Res 1995; 55: 4552-4556.
43. Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, Zhong S et al. PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor Rb. J Biol Chem 2001; 276: 43491-43494.